UnknownPhase 4

Indocyanine Green to Visualize Critical View of Safety During Laparoscopic Cholecystectomy for Acute Cholecystitis

Qatar80 participantsStarted 2021-01-01

Plain-language summary

The purpose of this prospective randomized trial is to study the role of Indocyanine green (ICG) to visualize the Critical View of Safety during emergency Laparoscopic Cholecystectomy for patients with Acute Cholecystitis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient scheduled for emergency Laparoscopic Cholecystectomy for Acute Cholecystitis * Patient age ≥ 18 years. * Patients who consent to take part in the study Exclusion Criteria: * Preoperative planned for Open Cholecystectomy * Allergy towards iodine, iohexol or ICG * Pregnancy or lactation * Renal insufficiency * Legally incompetent for any reason * Withdrawal of inclusion consent at any time * Prisoners

What they're measuring

Percentage of surgeries in which Critical View of Safety was achieved

Timeframe: Prior to clipping of the Cystic Duct and Cystic Artery or decision to perform conventional intraoperative cholangiography or convert to open.

Trial details

NCT IDNCT04624841

SponsorHamad Medical Corporation

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2021-12-31

Contact for this trial

Zia Aftab, MBBS, FACS

00974-66233904 zahmed5@hamad.qa

View on ClinicalTrials.gov More Acute Cholecystitis trials